Weijing Sun, MD is professor of medicine, Director of GI Cancer of Hematology-Oncology Division, Co-Director of UPMC Gastrointestinal Cancer Center of Excellence, University of Pittsburgh Cancer Institute. He served as associate professor of medicine, the director of GI Medical Oncology, an attending physician at University of Pennsylvania School of Medicine, Abramson Cancer Center of University of Pennsylvania until August 2012.
He is focusing on the treatment and clinical research of GI malignancies, mainly on the development of new drugs and biologic/targeted oriented agents in treatment/therapy (including translational research) of Gastrointestinal Malignancies with great experiences in the early phase clinical trial (phase I, II) designing, protocol development and conduction, and many of these have been published.
He has authored many publications including original clinical research articles, reviews, and invited editorial comments in a variety of peer-reviewed journals. He has also written chapters as a GI oncology expert for several medical textbooks including WebMD, Textbook of Gastroenterology. Has had more than 70 publications. He is serving as a member of editorial boards or review committees for several professional journals, including Clinical Colorectal Cancer, Journal of Clinical Gastroenterology, Journal of Clinical Oncology, Cancer, Disease of the Colon and Rectum, Cancer Biology and Therapy, Expert Opinion on Investigational Drugs, Pharmacogenomics, Gastroenterology, Expert Review of Anticancer Therapy, American Journal of Hematology-Oncology.
He is serving as a member of the NCI GI Steering Committee Hepatobiliary Task Force; a member of the ECOG GI core committee; in the ASCO Membership Committee. He is serving in the ASCO Scientific Program Committee. He also served as the President of CAHON (Chinese American Hematologist Oncologist Network).
He is an active member in the American College of Physicians, the American Medical Association, the American Society of Clinical Oncology, the American Association for Cancer Research, the Eastern Cooperative Group of Oncology, and the American College of Surgeons Oncology Group.
He has been named as a ‘Top-doctor’ by Philadelphia magazine and US News.